Tribal Group PLC
28 July 2006
Tribal Group plc 2006 AGM statement and announcement of preferred bidder status
on NHS diagnostic contract
At the Annual General Meeting of Tribal Group plc (the 'Group') to be held at
10.30 am today, Tribal will provide the following update:
'The Group is pleased to announce that its healthcare delivery business, Mercury
Health, has been appointed as preferred bidder to deliver a range of diagnostic
services to NHS patients in the West Midlands. Under the contract, Mercury
Health will be undertaking up to 190,000 diagnostic procedures annually for a
five year period. The contract is one of seven regional diagnostic contracts
to be awarded as part of the Phase 2 Independent Sector Treatment Centre
programme. Financial close is expected to be reached by the end of the year
and service delivery is due to commence during the first half of 2007
As anticipated in our preliminary statement on 20 June 2006, the weighting of
trading towards the second half of the year will be even more pronounced this
year with first half profits and earnings expected to be below last year.
The board remains confident about the Group's prospects.'
For further information please contact:
Tribal Group plc - 01285 886020
Henry Pitman, Chief Executive
Peter Martin, Chief Executive, Mercury Health
Simon Lawton, Group Finance Director
The Maitland Consultancy - 020 7379 5151
Colin Browne
Editors' note:
Tribal Group plc provides a range of consultancy and support services to the UK
public sector and healthcare services for the NHS. The Group's core markets are
in education; local government, housing and regeneration; health and social
care; and central government. The group employs 2,300 staff in the UK. Tribal
is quoted on the London Stock Exchange (TRB.L).
Links: Tribal Group plc website: www.tribalgroup.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.